Clinical Trials Browser

Observational × darolutamide × 1 year × Clear all

NCT06334120 2026-04-14

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Recruiting

600 enrolled

Genitourinary

Non-metastatic Castration-resistant Prostate Cancer

NCT07406282 2026-04-09

Double-DARE

Recruiting

1,400 enrolled

Genitourinary

Prostatic Neoplasms

NCT07344779 2026-04-03

ROAD

Active not recruiting

1,600 enrolled

Genitourinary

Prostatic Neoplasms

NCT06661122 2026-03-19

HAYATE

Recruiting

100 enrolled

Genitourinary

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT07428642 2026-03-18

PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.

Completed

168 enrolled

Genitourinary

Prostatic Neoplasms

NCT06724159 2026-02-17

SOGUG-PRINCIS

Recruiting

500 enrolled

Genitourinary

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT07395804 2026-02-17

23146

Not yet recruiting

500 enrolled

Genitourinary

Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

NCT07181122 2025-11-24

PRO-MIND

Recruiting

102 enrolled

Genitourinary

Depression, Fatigue, Sleep Initiation and Maintenance Disorders, Prostatic Neoplasms

NCT05202301 2025-08-11

A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely

Completed

13,779 enrolled

Genitourinary

Prostatic Neoplasms

NCT06013475 2025-06-12

DEAR-EXT

Completed

1,375 enrolled

Genitourinary

Non-metastatic Castration-resistant Prostate Cancer